Cost of Implementing an Evidence-Based Intervention to Support Safer Use of Antipsychotics in Youth.

[1]  R. Salloum,et al.  The economics of adaptations to evidence-based practices , 2022, Implementation Science Communications.

[2]  M. Campbell,et al.  Using economic evaluations in implementation science to increase transparency in costs and outcomes for organizational decision-makers , 2022, Implementation Science Communications.

[3]  T. Wagner,et al.  Cost data in implementation science: categories and approaches to costing , 2022, Implementation Science.

[4]  C. Correll,et al.  Development of a Symptom-Focused Model to Guide the Prescribing of Antipsychotics in Children and Adolescents: Results of the First Phase of the Safer and Targeted Use of Antipsychotics (SUAY) Clinical Trial. , 2021, Journal of the American Academy of Child and Adolescent Psychiatry.

[5]  D. Bowser,et al.  Cost analysis in implementation studies of evidence-based practices for mental health and substance use disorders: a systematic review , 2021, Implementation Science.

[6]  Joseph E. Glass,et al.  Costs of using evidence-based implementation strategies for behavioral health integration in a large primary care system. , 2020, Health services research.

[7]  J. Ralston,et al.  Safer use of antipsychotics in youth (SUAY) pragmatic trial protocol. , 2020, Contemporary clinical trials.

[8]  M. Olfson,et al.  Trends in Antipsychotic Medication Use in Young Privately Insured Children. , 2020, Journal of the American Academy of Child and Adolescent Psychiatry.

[9]  Thomas I. Mackie,et al.  Systematic Review: System-wide Interventions to Monitor Pediatric Antipsychotic Prescribing and Promote Best Practice. , 2020, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  Thomas I. Mackie,et al.  Effectiveness of mandatory peer review to reduce antipsychotic prescriptions for Medicaid-insured children. , 2020, Health services research.

[11]  Daniel Lewkowicz,et al.  Economic impact of clinical decision support interventions based on electronic health records , 2020, BMC Health Services Research.

[12]  Daniel Eisenberg,et al.  Economic evaluation in implementation science: Making the business case for implementation strategies , 2020, Psychiatry Research.

[13]  Robert B. Penfold,et al.  Designing Safer Use of Antipsychotics Among Youths: A Human-Centered Approach to an Algorithm-Based Solution. , 2019, Psychiatric services.

[14]  M. Bonati,et al.  Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data , 2019, European Journal of Clinical Pharmacology.

[15]  R. Bitsko,et al.  Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children , 2019, The Journal of pediatrics.

[16]  D. Safer,et al.  The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications. , 2017, Psychiatric services.

[17]  K. E. Melvin,et al.  Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid. , 2017, Psychiatric services.

[18]  R. Hilt,et al.  Decrease in Statewide Antipsychotic Prescribing after Implementation of Child and Adolescent Psychiatry Consultation Services , 2017, Health services research.

[19]  Irina O Karpov,et al.  Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[20]  Thomas I. Mackie,et al.  Rapid Growth Of Antipsychotic Prescriptions For Children Who Are Publicly Insured Has Ceased, But Concerns Remain. , 2016, Health affairs.

[21]  M. Olfson,et al.  Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis. , 2016, JAMA psychiatry.

[22]  R. Drake,et al.  Use of Antipsychotic Medications for Nonpsychotic Children: Risks and Implications for Mental Health Services. , 2016, Psychiatric services.

[23]  M. Olfson,et al.  Treatment of Young People With Antipsychotic Medications in the United States. , 2015, JAMA psychiatry.

[24]  E. Goplerud,et al.  Mental health and addiction workforce development: federal leadership is needed to address the growing crisis. , 2013, Health affairs.

[25]  Marie A. McPherson,et al.  Impact of the Florida Medicaid prior-authorization program on use of antipsychotics by children under age six. , 2012, Psychiatric services.

[26]  C. Vogeli,et al.  Effect of electronic prescribing with formulary decision support on medication use and cost. , 2008, Archives of internal medicine.

[27]  M. Crismon,et al.  Trends in the use of typical and atypical antipsychotics in children and adolescents. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[28]  Thomas I. Mackie,et al.  Antipsychotic Use Among Youth in Foster Care Enrolled in a Specialized Managed Care Organization Intervention. , 2020, Journal of the American Academy of Child and Adolescent Psychiatry.

[29]  J. Kelman,et al.  Pediatric Use of Antipsychotic Medications Before and After Medicaid Peer Review Implementation , 2018, JAMA psychiatry.